Last reviewed · How we verify
NCT03410381: EMMA
Ecological Momentary Mental Assessment
NA trial testing Application EMMA in Person at Risk of Suicide in 97 participants. Completed in 26 June 2020.
26 June 2020
Quick facts
| Lead sponsor | University Hospital, Montpellier |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 97 |
| Start date | 31 May 2018 |
| Primary completion | 26 June 2020 |
| Estimated completion | 26 June 2020 |
| Sites | 1 location across France |
Drugs / interventions tested
- Application EMMA
Conditions studied
- Person at Risk of Suicide — all drugs for Person at Risk of Suicide →
Sponsor
University Hospital, Montpellier
Who can join
18 and older, any sex, with Person at Risk of Suicide. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Suicide is a major health problem that causes annually a million death worldwide. Suicide and suicide attempts are preventable. A history of self-injuries or suicidal attempts are known to be the most important risk factor for death by suicide. Suicidal ideation is also strongly correlated with suicide attempts. The development of Smartphones applications offers new possibilities for data collection and transmission. Moreover, the online help function, when a suicidal crisis occurs, is the most effective strategy for prevention of suicidal behavior. Specific technologies have been developed to analyse behaviors and experiences of patients in a natural environment, in real life. That is the goal of Ecological Momentary Assessment. The aim of the study is to develop an algorithm to assess and predict the risk of suicidal event occurrence, in order to detect as soon as possible the signs of suicidal crisis. EMMA will be the first application in French, meeting the recommendations for health applications, developed by experts on suicidal behavior and in collaboration with patients which aims to predict suicidal risk. A subsequent study, conducted on a larger population, should allow to validate the predictive algorithm of EMMA. Long-term goal is to improve the care of patients at risk for suicidal behavior.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
A Digital Companion, the Emma App, for Ecological Momentary Assessment and Prevention of Suicide: Quantitative Case Series Study.
Morgiève M, Genty C, Azé J, Dubois J, et al · · 2020 · cited 22× · PMID 33034567 · DOI 10.2196/15741 -
Ethical issues and practical barriers in internet-based suicide prevention research: a review and investigator survey.
Bailey E, Mühlmann C, Rice S, Nedeljkovic M, et al · · 2020 · cited 22× · PMID 32404098 · DOI 10.1186/s12910-020-00479-1 -
Acceptability and satisfaction with <i>emma</i>, a smartphone application dedicated to suicide ecological assessment and prevention.
Morgiève M, Yasri D, Genty C, Dubois J, et al · · 2022 · cited 7× · PMID 36032223 · DOI 10.3389/fpsyt.2022.952865 -
Predicting suicidal ideation from irregular and incomplete time series of questionnaires in a smartphone-based suicide prevention platform: a pilot study.
Quellec G, Berrouiguet S, Morgiève M, Dubois J, et al · · 2024 · PMID 39242628 · DOI 10.1038/s41598-024-71760-1
Verify or expand the search:
- PubMed search for NCT03410381
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University Hospital, Montpellier trials
Trials by the same sponsor.
- NCT07524127 — Phenotyping of Type 2 Inflammation Profile by Rheology of Nasal Secretions and Tissue Quantification of Eosinophilic Pol · NA · not yet recruiting
- NCT07255495 — Effects of Neuromuscular Scoliosis Surgery on Nutritional Metabolism · NA · not yet recruiting
- NCT07534189 — Prospective Cohort Study Evaluating a Thermal Spa Programme in Symptomatic Knee Osteoarthritis · NA · not yet recruiting
- NCT07515638 — Immun4Cure Cohort of Autoimmune Diseases · not yet recruiting
- NCT07406516 — Identification of Kinematic Variables Specific of Patellar Tendinopathy in Athletes at Risk · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03410381 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Montpellier
- Last refreshed: 5 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03410381.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing